Apr 25 |
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
|
Apr 18 |
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
|
Apr 12 |
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
Mar 12 |
Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now
|
Mar 11 |
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
|
Mar 6 |
BioVie Inc. Announces Closing of Public Offering
|
Mar 4 |
BioVie stock plunges 43% following public offering pricing
|
Mar 4 |
BioVie slumps 18%, prices $21M equity offering
|
Mar 4 |
BioVie Inc. Announces Pricing of Public Offering
|
Mar 1 |
BioVie Inc. Announces Proposed Public Offering of Common Stoc
|